A practical reference on lyophilized powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-02-19. Anything still debated is marked as such rather than presented as settled.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
== Types of proteomes == While proteome generally refers to the proteome of an organism, multicellular organisms may have very different proteomes in different cells, hence it is important to distinguish proteomes in cells and organisms. A cellular proteome is the collection of proteins found in a particular cell type under a particular set of environmental conditions such as exposure to hormone stimulation. It can also be useful to consider an organism's complete proteome, which can be conceptualized as the complete set of proteins from all of the various cellular proteomes. This is very roughly the protein equivalent of the genome. The term proteome has also been used to refer to the collection of proteins in certain sub-cellular systems, such as organelles. For instance, the mitochondrial proteome may consist of more than 3000 distinct proteins. The proteins in a virus can be called a viral proteome. Usually viral proteomes are predicted from the viral genome but some attempts have been made to determine all the proteins expressed from a virus genome, i.e. the viral proteome. More often, however, virus proteomics analyzes the changes of host proteins upon virus infection, so that in effect two proteomes (of virus and its host) are studied.
=== Mortality, all-causes === Vitamin D3 supplementation has been tentatively found to lead to a reduced risk of death in the elderly, but the effect has not been deemed pronounced, or certain enough, to make taking supplements recommendable. Other forms (vitamin D2, alfacalcidol, and calcitriol) do not appear to have any beneficial effects concerning the risk of death. High blood levels appear to be associated with a lower risk of death, but it is unclear if supplementation can result in this benefit. Both an excess and a deficiency in vitamin D appear to cause abnormal functioning and premature aging. The relationship between serum calcifediol concentrations and all-cause mortality is "U-shaped": mortality is elevated at high and low calcifediol levels, relative to moderate levels. Harm from elevated calcifediol appears to occur at a lower level in dark-skinned Canadian and American populations than in light-skinned populations.
At the same time, the Central Intelligence Agency (CIA) was accused of facilitating the drug trade in Mexico and elsewhere to fund anticommunist guerilla forces in Central and South America. A number of former DEA agents, CIA agents, Mexican police officers, and historians contend that the CIA was complicit in the murder of DEA agent Kiki Camarena, who discovered and attempted to reveal the CIA's role in the drug trade. Between 2013 and 2015, the Mexican newspaper Proceso, journalist Jesús Esquivel, journalists Charles Bowden and Molly Malloy, and historians Russell and Silvia Bartley published investigative reports and books making the same allegation. They wrote that Camarena, like Mexican journalist Manuel Buendía, discovered that the CIA helped organize drug trafficking from Mexico into the United States to fund the anti-communist Contras in Nicaragua as a part of the Cold War. Historian Wil Pansters explained that US victory in the Cold War was more important to the CIA than the DEA's war on drugs:Since the overriding concern of the CIA was the anti-Sandinista project, it trumped the DEA's task of combating drug trafficking, and covertly incorporated (or pressured) parts of the Mexican state into subservience. Buendía had found out about the CIA-contra-drugs-DFS connection, which seriously questioned Mexican sovereignty, while Camarena learned that the CIA had infiltrated the DEA and sabotaged its work so as to interfere with the clandestine contra-DFS-traffickers network. They knew too much and were eliminated on the orders of the U.S. with Mexican complicity.
==== X-ray diffraction ==== A case study by Beale et al. involved preparation of iron phosphates and bismuth molybdate catalysts from an amorphous precursor gel. The study found that there were no intermediate phases in the reaction, and helped to determine kinetic and structural information. The article uses the dated term in-situ, but the experiment uses, in essence, an operando method. Although x-ray diffraction does not count as a spectroscopy method, it is often being used as an operando method in various fields, including catalysis.
SCGJWD Logistics Public Company Limited (SCGJWD; SET: SJWD) was established through a partnership merger between SCG Logistics Management Co., Ltd. (SCGL), a subsidiary of Siam Cement Group, and JWD InfoLogistics (JWD). The share swap transaction was completed on February 14, 2023, and the trading symbol was changed to "SJWD" on February 17, 2023. SCGJWD Logistics Public Company Limited is an integrated logistics service provider with expertise in industrial products, general goods, chemicals, automotive goods and cold chain storage.
Sources: en.wikipedia.org
Hungarian sausages – the cuisine of Hungary produces a vast number of types of sausages. Different regions in Hungary may have their own sausage recipes and tastes. The Hungarian sausages may be boiled, fresh or dried and smoked, with different spices and flavors, "hot" or "mild".
In contrast, the border with Canada is primarily maintained through joint border patrol and security camera programs, making it the world's longest undefended border. In remote areas along the border with Canada, where staffed border crossings are unavailable, there are hidden sensors on roads, trails, railways, and wooded areas near crossing points. Members of the Schengen Agreement are required to apply strict checks on travellers entering and exiting the area. These checks are coordinated by the European Union's Frontex agency, and subject to common rules. The details of border controls, surveillance and the conditions under which permission to enter into the Schengen Area may be granted are exhaustively detailed in the Schengen Borders Code. All persons crossing external borders are subject to a check by a border guard. The only exception is for regular cross-border commuters (both those with the right of free movement and third-country nationals) who are well known to the border guards: once an initial check has shown that there is no alert on record relating to them in the Schengen Information System or national databases, they can only be subject to occasional 'random' checks, rather than systematic checks every time they cross the border. Additionally, border security in Europe is increasingly being outsourced to private companies, with the border security market growing at a rate of 7% per year.
pachynema Also pachytene stage. In meiosis, the third of five substages of prophase I, following zygonema and preceding diplonema. During pachynema, the synaptonemal complex facilitates crossing over between the synapsed homologous chromosomes, and the centrosomes begin to move apart from each other.
Rural tourism, focusing on getting visitors acquainted with local folklore and customs, has become an important alternative, and is targeted to promote such sites as Bran and its Dracula's Castle, the painted churches of northern Moldavia, and the wooden churches of Maramureș, or the villages with fortified churches in Transylvania. The Via Transilvanica long-distance hiking and cycling trail, which crosses 10 counties in the Transylvania, Banat and Bukovina regions of the country further promotes rural slow tourism. Other important itineraries include Via Mariae, EuroVelo 6 and 13, etc. In 2014, Romania had 32,500 companies active in the hotel and restaurant industry, with a total turnover of €2.6 billion. More than 1.9 million foreign tourists visited Romania in 2014, 12% more than in 2013. According to the country's National Statistics Institute, some 77% came from Europe (particularly from Germany, Italy, and France), 12% from Asia, and less than 7% from North America.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.